Neha J. Pagidipati

Preventive Cardiology

Alnylam Pharmaceuticals (United States)

About

Neha J. Pagidipati works in Preventive Cardiology affiliated with Alnylam Pharmaceuticals (United States).

Neha J. Pagidipati is an Associate Professor of Medicine at Duke University School of Medicine and a member of the Duke Clinical Research Institute. She specializes in cardiovascular disease prevention and is building the Duke Cardiometabolic Disease Prevention Program for patients with high risk of cardiovascular and metabolic diseases. She has served as a study clinician on the EXSCEL trial and is involved in the COORDINATE-Diabetes Trial.

Research focus

Cardiometabolic disease preventionDiabetes and cardiovascular risk managementObesity management in cardiovascular diseaseLifestyle interventions for heart diseaseImplementation science in cardiology

Impact

274 pubs · 7,806 cites · h-index 38

Training

MD
Harvard Medical School
2008
MPH
Harvard School of Public Health
2013

Affiliations

Work Experience

Associate Professor of Medicine

Duke University School of Medicine · 2025 - Present

Member

Duke Clinical Research Institute · 2017 - Present

Cardiology Fellow

Duke University School of Medicine · 2013 - 2017

Research Fellow in Global Women’s Health

Brigham and Women’s Hospital · 2011 - 2013

Internal Medicine Resident

Brigham and Women’s Hospital · 2008 - 2011